Alenson Carman

Other

US·SEC (Form 4)

AGIOS PHARMACEUTICALS, INC.Agios Pharmaceuticals, INC.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the complete record of transactions filed by Alenson Carman. Officer active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. Cumulatively, 2 filings have been published. The latest transaction was filed on 21 June 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.

Declarations2 total

Executives◇OptionsAAGIOS PHARMACEUTICALS, INC.21SEC

A

Alenson CarmanPrincipal Accounting Officer

€76,8381,777 shares@ €43.2401100.0% of flow

Common stock

SEC:0001439222-21-000060·21 Jun 2021

SEC ↗

Executives◇OptionsAAgios Pharmaceuticals, INC.32SEC

A

Alenson CarmanPrincipal Accounting Officer

€76,8381,777 shares@ €43.24010.0046% mcap100.0% of flow